These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 16715670

  • 21. Effects of employing a ¹⁰B-carrier and manipulating intratumour hypoxia on local tumour response and lung metastatic potential in boron neutron capture therapy.
    Masunaga S, Sakurai Y, Tanaka H, Suzuki M, Liu Y, Kondo N, Maruhashi A, Kinashi Y, Ono K.
    Br J Radiol; 2012 Mar; 85(1011):249-58. PubMed ID: 22391496
    [Abstract] [Full Text] [Related]

  • 22. Evaluating the Usefulness of a Novel 10B-Carrier Conjugated With Cyclic RGD Peptide in Boron Neutron Capture Therapy.
    Masunaga SI, Kimura S, Harada T, Okuda K, Sakurai Y, Tanaka H, Suzuki M, Kondo N, Maruhashi A, Nagasawa H, Ono K.
    World J Oncol; 2012 Jun; 3(3):103-112. PubMed ID: 29147290
    [Abstract] [Full Text] [Related]

  • 23. Effects of boron neutron capture therapy using borocaptate sodium in combination with a tumor-selective vasoactive agent in mice.
    Ono K, Masunaga S, Kinashi Y, Takagaki M, Akaboshi M, Suzuki M, Baba H.
    Jpn J Cancer Res; 1998 Mar; 89(3):334-40. PubMed ID: 9600129
    [Abstract] [Full Text] [Related]

  • 24. The combined effect of boronophenylalanine and borocaptate in boron neutron capture therapy for SCCVII tumors in mice.
    Ono K, Masunaga S, Suzuki M, Kinashi Y, Takagaki M, Akaboshi M.
    Int J Radiat Oncol Biol Phys; 1999 Jan 15; 43(2):431-6. PubMed ID: 10030272
    [Abstract] [Full Text] [Related]

  • 25. Electroporation increases the effect of borocaptate (10B-BSH) in neutron capture therapy.
    Ono K, Kinashi Y, Masunaga S, Suzuki M, Takagaki M.
    Int J Radiat Oncol Biol Phys; 1998 Nov 01; 42(4):823-6. PubMed ID: 9845104
    [Abstract] [Full Text] [Related]

  • 26. Potential of alpha-amino alcohol p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, regarding its enantiomers.
    Masunaga S, Ono K, Kirihata M, Takagaki M, Sakurai Y, Kinashi Y, Kobayashi T, Suzuki M, Nagata K, Nagasawa H, Uto Y, Hori H.
    J Cancer Res Clin Oncol; 2003 Jan 01; 129(1):21-8. PubMed ID: 12618897
    [Abstract] [Full Text] [Related]

  • 27. Cationized gelatin-HVJ envelope with sodium borocaptate improved the BNCT efficacy for liver tumors in vivo.
    Fujii H, Matsuyama A, Komoda H, Sasai M, Suzuki M, Asano T, Doki Y, Kirihata M, Ono K, Tabata Y, Kaneda Y, Sawa Y, Lee CM.
    Radiat Oncol; 2011 Jan 20; 6():8. PubMed ID: 21247507
    [Abstract] [Full Text] [Related]

  • 28. Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells.
    Masunaga S, Ono K, Nishimura Y, Kanamori S, Saga T, Suzuki M, Kinashi Y, Takagaki M, Kasai S, Nagasawa H, Uto Y, Hori H.
    Int J Radiat Oncol Biol Phys; 2000 Jun 01; 47(3):799-807. PubMed ID: 10837967
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
    Futamura G, Kawabata S, Nonoguchi N, Hiramatsu R, Toho T, Tanaka H, Masunaga SI, Hattori Y, Kirihata M, Ono K, Kuroiwa T, Miyatake SI.
    Radiat Oncol; 2017 Jan 23; 12(1):26. PubMed ID: 28114947
    [Abstract] [Full Text] [Related]

  • 30. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
    Obayashi S, Kato I, Ono K, Masunaga S, Suzuki M, Nagata K, Sakurai Y, Yura Y.
    Oral Oncol; 2004 May 23; 40(5):474-82. PubMed ID: 15006618
    [Abstract] [Full Text] [Related]

  • 31. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
    Maruyama K, Ishida O, Kasaoka S, Takizawa T, Utoguchi N, Shinohara A, Chiba M, Kobayashi H, Eriguchi M, Yanagie H.
    J Control Release; 2004 Aug 11; 98(2):195-207. PubMed ID: 15262412
    [Abstract] [Full Text] [Related]

  • 32. The effectiveness of the high-LET radiations from the boron neutron capture [10B(n,α) 7Li] reaction determined for induction of chromosome aberrations and apoptosis in lymphocytes of human blood samples.
    Schmid TE, Canella L, Kudejova P, Wagner FM, Röhrmoser A, Schmid E.
    Radiat Environ Biophys; 2015 Mar 11; 54(1):91-102. PubMed ID: 25428113
    [Abstract] [Full Text] [Related]

  • 33. Boron neutron capture therapy of brain tumors: biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas.
    Goodman JH, Yang W, Barth RF, Gao Z, Boesel CP, Staubus AE, Gupta N, Gahbauer RA, Adams DM, Gibson CR, Ferketich AK, Moeschberger ML, Soloway AH, Carpenter DE, Albertson BJ, Bauer WF, Zhang MZ, Wang CC.
    Neurosurgery; 2000 Sep 11; 47(3):608-21; discussion 621-2. PubMed ID: 10981748
    [Abstract] [Full Text] [Related]

  • 34. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
    Barth RF, Yang W, Rotaru JH, Moeschberger ML, Joel DD, Nawrocky MM, Goodman JH, Soloway AH.
    Cancer Res; 1997 Mar 15; 57(6):1129-36. PubMed ID: 9067283
    [Abstract] [Full Text] [Related]

  • 35. Biodistribution of sodium borocaptate (BSH) for boron neutron capture therapy (BNCT) in an oral cancer model.
    Garabalino MA, Heber EM, Monti Hughes A, González SJ, Molinari AJ, Pozzi EC, Nievas S, Itoiz ME, Aromando RF, Nigg DW, Bauer W, Trivillin VA, Schwint AE.
    Radiat Environ Biophys; 2013 Aug 15; 52(3):351-61. PubMed ID: 23591915
    [Abstract] [Full Text] [Related]

  • 36. Radiobiological evidence suggesting heterogeneous microdistribution of boron compounds in tumors: its relation to quiescent cell population and tumor cure in neutron capture therapy.
    Ono K, Masunaga SI, Kinashi Y, Takagaki M, Akaboshi M, Kobayashi T, Akuta K.
    Int J Radiat Oncol Biol Phys; 1996 Mar 15; 34(5):1081-6. PubMed ID: 8600091
    [Abstract] [Full Text] [Related]

  • 37. Combination of the antivascular agent ZD6126 with hypoxic cytotoxin treatment, with reference to the effect on quiescent tumor cells and the dependency on p53 status of tumor cells.
    Masunaga S, Nagasawa H, Uto Y, Hori H, Ohnishi K, Takahashi A, Ohnishi T, Suzuki M, Nagata K, Kinashi Y, Ono K.
    Oncol Rep; 2005 Aug 15; 14(2):393-400. PubMed ID: 16012721
    [Abstract] [Full Text] [Related]

  • 38. The dependency of compound biological effectiveness factors on the type and the concentration of administered neutron capture agents in boron neutron capture therapy.
    Masunaga S, Sakurai Y, Tanaka H, Tano K, Suzuki M, Kondo N, Narabayashi M, Nakagawa Y, Watanabe T, Maruhashi A, Ono K.
    Springerplus; 2014 Aug 15; 3():128. PubMed ID: 25674433
    [Abstract] [Full Text] [Related]

  • 39. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
    Barth RF, Yang W, Rotaru JH, Moeschberger ML, Boesel CP, Soloway AH, Joel DD, Nawrocky MM, Ono K, Goodman JH.
    Int J Radiat Oncol Biol Phys; 2000 Apr 01; 47(1):209-18. PubMed ID: 10758326
    [Abstract] [Full Text] [Related]

  • 40. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption.
    Yang W, Barth RF, Rotaru JH, Moeschberger ML, Joel DD, Nawrocky MM, Goodman JH, Soloway AH.
    Int J Radiat Oncol Biol Phys; 1997 Feb 01; 37(3):663-72. PubMed ID: 9112465
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.